Journals / Medical Network Klinik Bilimler ve Doktor / 2000 / Cilt: 6 - Sayı: 2

The lipoprotein (a) elevation effect of hemodialysis on different patients group

Hemodializin farklı hasta gruplarında LP(a)' yı yükseltici etkisi

Pages
165–167
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the long term, this acute negative effect may increase the mortality and morbidity of these diabetic and vascular disease positive risky patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Lipoprotein (a) [Lp(a)] is atherogenic as little dansity lipoprotein (LDL) like particle and thrombogenic as plasminogen.
📊
Key Findings & Data:MATERIAL AND METHODS: 70 chronic renal failure patients, who would be dialysed for the first time, are chosen.
💡
Conclusion & Impact:In the long term, this acute negative effect may increase the mortality and morbidity of these diabetic and vascular disease positive risky patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Lipoprotein(a) · Akut faz proteinleri · Böbrek yetmezliği

Abstract

OBJECTIVE: Lipoprotein (a) [Lp(a)] is atherogenic as little dansity lipoprotein (LDL) like particle and thrombogenic as plasminogen. In some studies, it is shown that Lp(a) is elevated during the hemodialysis procedure. This study is performed to see the acute effect of hemodialysis on different risky patient groups and to determine the difference between them, if there is. MATERIAL AND METHODS: 70 chronic renal failure patients, who would be dialysed for the first time, are chosen. Twelve of them had both diabetes mellitus and vascular disease, 8 of them had only vascular disease, 20 of them had vascular disease with diabetes or not, 50 of them had neither diabetes nor vascular disease. Pre and post dialysis values were compared, for all groups. RESULTS: There was a significant increase for all patients after dialysis (p<0.0l,<0.05,<0.05,<0.05 respectively). But the difference of elevation level was quantitatively higher than the other groups, in the group of patients with diabetes and vascular disease (p<0.05). Vascular disease or diabetes had no significant different effect on predialysis levels of Lp(a) (p>0.05). CONCLUSIONS: Hemodialysis has an acute negative effect on the patients. The cause of this acute increase is still unknown. This acute harmful effect became more significant in the presence of additional disorders like diabetes or vascular disease or both. In the long term, this acute negative effect may increase the mortality and morbidity of these diabetic and vascular disease positive risky patients.

Özet

AMAÇ: Düşük dansiteli lipoprotein (LDL) 'ye benzer özellikleri ile aterojenik, plazminojene benzer özellikleri ile trombojenik olan Lipoprotein(a) nın [Lp(a)]'nın, hemodializ sırasında yükseldiği bazı çalışmalarda gösterilmiştir. Bu çalışma hemodializin Lp(a) üzerindeki akut etkisini, riskli hasta gruplarında değerlendirmek amacıyla yapılmıştır. GEREÇ VE YÖNTEM: Hemodialize ilk kez giren, 70 kişilik kronik böbrek yetmezlikli hasta, diabetes mellitus+vasküler hastalığı olan (n = 12), sadece vasküler hastalığı olan (n=8), diabeti olan ve olmayan vasküler hastalığı (+) olan hastalar (n=20), diabeti ve vasküler hastalığı olmayan (n=50 )hastalar olarak gruplandırılmıştır. Bu hasta gruplarında dializ öncesi ve dializ sonrası Lp(a) değerlerine bakılmıştır. BULGULAR: Tüm hasta gruplarında dializ sonrasında Lp(a) 'da anlamlı yükselme olmuştur (sırasıyla p 0.05). SONUÇ: Hemodializin Lp(a) 'yi akut yükseltici etkisi vardır. Bu yükselmenin nedeni halen kesin olarak bilinmemekle birlikte, diabet ve damar hastalığı gibi ek hastalıkların varlığı ve bunların sayısının artması ile bu olumsuz etki belirginleşmektedir. Bu akut olumsuz etki, uzun dönemde diabeti ve damar hastalığı olan riskli hasta grubunda kardiovasküler mortalite ve morbiditeyi daha fazla arttırabilir.

🔖

Cite This Article

ZÜMRÜTDAL, Ö. A., ADANALI, S., TURHAN, T. (2000). The lipoprotein (a) elevation effect of hemodialysis on different patients group. Medical Network Klinik Bilimler ve Doktor, Cilt: 6 - Sayı: 2, 165–167. https://ajindex.com/articles/278789

References (1)

  1. Scumacher M, Keffer M, Bahimann G, Wood G. Acute changes in concentrations of apoiipoproteins A.B.CII and lipoprotein (a) in serum covering the period from directly before to 48 hours after chronic hemodialysis. Eur.J.Clin Cliem Clin Biochem 1994; 32(3): 123-125. 2.Kronenberg F. Lipoprotein(a) in renal disease, what we have, what we need, what we can forget. Nephrology Dial Transplant 1995:766-768. 3.Tzanatos H, Fourtounas C, Agroyannis B, Chondros, Dalamangas A. Bossiolis B. Kopelias I, Koutsikos D. Alterations of plasma lipoprotein(a) concentration Do they arise from the hemodialysis procedure?Nephrology Dialysis Transplant 1996; 11 (7): 1491-2. 4.Levine DM, Gordon BR. Lipoprotein(a) levels in patients receiving renal replacement therapy: Methodologic issues and clinical implications Am J Kidney Disease 1995;26:162-169. 5.Kario K, Matsuo T, Kobayashi H, Matsuo M. Asada R, Koide M High lipoprotein(a) levels in chronic hemodialysis patients are closely related to acute phase reaction. Thromb Haemost 1995;74(4): 1020-1024. 6.Docci D, Capponcini C, Mengozzis D, Baldrati L, Neri L, Feletti C. Effects of different dialysis memranes on lipid and lipoprotein serum profiles in hemodialysis patients. Nephron 1995;69:323-326.